Developing renewable human liver tissue from stem cells has been pursued as a potential source of biological material for pharmaceutical and clinical endeavors. At present, two-dimensional differentiation procedures deliver tissue lacking long-term phenotypic and functional stability. Efforts to overcome these limiting factors have led to the development of protocols to generate three-dimensional cellular aggregates. Here we describe a methodology to generate 3D hepatospheres from human pluripotent stem cells using defined and commercially available reagents
Liver transplantation is the only effective treatment of end-stage liver disease, but it is limited ...
Hepatic differentiation of human?induced pluripotent stem cells (hiPSCs) under flow conditions in a ...
Chronic liver diseases represent a primary worldwide health concern. Liver transplantation is the on...
The video component (running time: 06:57) of this article can be found at https://www.jove.com/video...
Liver disease is an escalating global health issue. While liver transplantation is an effective mode...
Liver disease is an escalating global health issue. While liver transplantation is an effective mode...
Liver cell therapy and in vitro models require functional human hepatocytes, the sources of which ar...
Human pluripotent stem cells (hPSCs) can self-renew indefinitely in vitro while maintaining the capa...
Background and objectives of the study: This master’s thesis consists of three parts involving induc...
The therapeutic potential of human pluripotent stem (hPS) cells is threatened by the difficulty to h...
The liver carries out a range of functions essential for bodily homeostasis. The impairment of liver...
Primary human hepatocytes are a scare resource with limited lifespan and variable function which di...
Human embryonic stemcells (hESCs) and induced pluripotent stemcells (iPSCs) provide an unlimited sou...
Human hepatocytes, suitable for treatment of patients with liver failure, for the creation of bioart...
The hepatic differentiation of human induced pluripotent stem cells (hiPSC) holds great potential fo...
Liver transplantation is the only effective treatment of end-stage liver disease, but it is limited ...
Hepatic differentiation of human?induced pluripotent stem cells (hiPSCs) under flow conditions in a ...
Chronic liver diseases represent a primary worldwide health concern. Liver transplantation is the on...
The video component (running time: 06:57) of this article can be found at https://www.jove.com/video...
Liver disease is an escalating global health issue. While liver transplantation is an effective mode...
Liver disease is an escalating global health issue. While liver transplantation is an effective mode...
Liver cell therapy and in vitro models require functional human hepatocytes, the sources of which ar...
Human pluripotent stem cells (hPSCs) can self-renew indefinitely in vitro while maintaining the capa...
Background and objectives of the study: This master’s thesis consists of three parts involving induc...
The therapeutic potential of human pluripotent stem (hPS) cells is threatened by the difficulty to h...
The liver carries out a range of functions essential for bodily homeostasis. The impairment of liver...
Primary human hepatocytes are a scare resource with limited lifespan and variable function which di...
Human embryonic stemcells (hESCs) and induced pluripotent stemcells (iPSCs) provide an unlimited sou...
Human hepatocytes, suitable for treatment of patients with liver failure, for the creation of bioart...
The hepatic differentiation of human induced pluripotent stem cells (hiPSC) holds great potential fo...
Liver transplantation is the only effective treatment of end-stage liver disease, but it is limited ...
Hepatic differentiation of human?induced pluripotent stem cells (hiPSCs) under flow conditions in a ...
Chronic liver diseases represent a primary worldwide health concern. Liver transplantation is the on...